DGRO vs VHT
iShares Core Dividend Growth ETF vs Vanguard Health Care ETF
- • DGRO has the lower expense ratio at 0.08% vs 0.09% for VHT.
- • DGRO pays a higher dividend yield (2.00%).
Side-by-side metrics
| Metric | DGRO | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.09% |
Dividend yield Trailing 12-month yield. | 2.00% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $39.65B | $18.51B |
YTD return | 6.49% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.72 | 0.64 |
P/E ratio | 22.67 | 25.44 |
Last price | $73.08 | $271.09 |
Inception | — | — |
Issuer | iShares | Vanguard |
DGRO top holdings
| AVGO | Broadcom Inc | 3.25% |
| JPM | JPMorgan Chase & Co | 3.04% |
| AAPL | Apple Inc | 2.93% |
| MSFT | Microsoft Corp | 2.91% |
| XOM | Exxon Mobil Corp | 2.90% |
| JNJ | Johnson & Johnson | 2.64% |
| ABBV | AbbVie Inc | 2.52% |
| UNH | UnitedHealth Group Inc | 2.31% |
| PG | Procter & Gamble Co | 2.07% |
| PM | Philip Morris International Inc | 1.94% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About DGRO
DGRO (iShares Core Dividend Growth ETF) is US stocks with sustained dividend growth. Managed by iShares, the fund carries $39.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 2.00%. Its largest holding is Broadcom Inc (AVGO), which represents 3.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.7%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.